Long life polypeptide binding molecules
AssigneeAmgen Research (Munich) GmbH
InventorsPeter Kufer, Tobias Raum, Ralf Lutterbüse, Markus Muenz, Johannes Brozy, Majk Kvesic, Patrick Hoffmann
Life of this patent
Estimating the term…
Loading patent…
AssigneeAmgen Research (Munich) GmbH
InventorsPeter Kufer, Tobias Raum, Ralf Lutterbüse, Markus Muenz, Johannes Brozy, Majk Kvesic, Patrick Hoffmann
Estimating the term…
The present invention relates to a binding molecule comprising at least three domains comprised in at least one polypeptide chain, wherein the first binding domain is a binding domain which is capable of binding to a cell surface molecule on a target cell, the second binding domain is a binding domain which is capable of binding to the T cell CD3 receptor complex, and the third domain is a binding domain which is capable of binding to serum albumin, wherein said third domain is positioned at the C-terminus of said second domain. Moreover, the invention provides a nucleic acid sequence encoding the binding molecule, a vector comprising said nucleic acid sequence and a host cell transformed or transfected with said vector. Furthermore, the invention provides a process for the production of the binding molecule of the invention, a medical use of said binding molecule and a kit comprising said binding molecule.
A binding molecule comprising at least three binding domains comprised in at least one polypeptide chain, wherein
17-20. (canceled)
(canceled)
Dependencies are inferred from the claim text.